Notice2026-10549
Certain Medical Imaging Devices; Notice of Commission Determination Not To Review an Initial Determination Granting Complainants' Motion To Amend the Complaint and Notice of Investigation
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
May 28, 2026
Issuing agencies
International Trade Commission
Abstract
Notice is hereby given that the U.S. International Trade Commission has determined not to review an initial determination ("ID") (Order No. 12) of the presiding administrative law judge ("ALJ") granting an unopposed motion to amend the complaint and notice of investigation to add University Health Network ("UHN") as a co-complainant.
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 102 (Thursday, May 28, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 102 (Thursday, May 28, 2026)]
[Notices]
[Pages 31745-31746]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-10549]
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation No. 337-TA-1483]
Certain Medical Imaging Devices; Notice of Commission
Determination Not To Review an Initial Determination Granting
Complainants' Motion To Amend the Complaint and Notice of Investigation
AGENCY: U.S. International Trade Commission.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that the U.S. International Trade
Commission has determined not to review an initial determination
(``ID'') (Order No. 12) of the presiding administrative law judge
(``ALJ'') granting an unopposed motion to amend the complaint and
notice of investigation to add University Health Network (``UHN'') as a
co-complainant.
FOR FURTHER INFORMATION CONTACT: B. Rashmi Borah, Esq., Office of the
General Counsel, U.S. International Trade Commission, 500 E Street SW,
Washington, DC 20436, telephone (202) 205-2518. Copies of non-
confidential documents filed in connection with this investigation may
be viewed on the Commission's electronic docket (EDIS) at <a href="https://edis.usitc.gov">https://edis.usitc.gov</a>. For help accessing EDIS, please email
<a href="/cdn-cgi/l/email-protection#fdb8b9b4aeceb598918dbd888e94899ed39a928b"><span class="__cf_email__" data-cfemail="d792939e84e49fb2bba797a2a4bea3b4f9b0b8a1">[email protected]</span></a>. General information concerning the Commission may
also be obtained by accessing its internet server at <a href="https://www.usitc.gov">https://www.usitc.gov</a>. Hearing-impaired persons are advised that information on
this matter can be obtained by contacting the Commission's TDD
terminal, telephone (202) 205-1810.
SUPPLEMENTARY INFORMATION: The Commission instituted this investigation
on February 2, 2026, based on a complaint filed by MolecuLight Inc. of
Toronto, Ontario, Canada and MolecuLight Corp. of Pittsburgh,
Pennsylvania (collectively, ``Complainants''). 91 FR 4629-30 (Feb. 2,
2026). The complaint, as supplemented, alleges violations of section
337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, based upon
the importation into the United States, the sale for importation, and
the sale within the United States after importation of certain medical
imaging devices by reason of the infringement of certain claims of U.S.
Patent No. 10,438,356 (``the `356 patent''). Id. at 4629. The complaint
further alleges that a domestic industry exists. Id. The notice of
investigation names two respondents: (1) Kent Imaging Inc. of Calgary,
Alberta, Canada; and (2) Adiuvo Diagnostics Pvt. Ltd. of Chennai, India
(collectively, ``Respondents''). Id. The Office of Unfair Import
Investigations (``OUII'') is also named as a party to this
investigation. Id.
On May 8, 2026, Complainants filed a motion seeking leave to amend
the complaint and notice of investigation to add the owner of the `356
patent, UHN, as a co-complainant in this investigation. Complainants'
motion certified that neither Respondents nor OUII oppose the motion.
On May 11, 2026, the ALJ issued the subject ID (Order No. 12)
granting Complainants' unopposed motion. The ID finds that
Complainants' motion complies with Commission Rule 210.14(b), 19 CFR
210.14(b), and also finds that Complainants showed good cause to amend
the complaint to add UHN as a co-complainant because ``joinder would
moot Respondents' pending motion for summary determination asserting
that UHN is an indispensable party . . . and streamline discovery by
avoiding international judicial process.'' ID at 2. Complainants filed
an amended complaint naming UHN as a co-complainant on May 12, 2026. No
party filed a petition for review of the ID.
The Commission has determined not to review the subject ID.
Accordingly, the complaint and notice of investigation are amended to
include UHN as a co-complainant.
The Commission vote for this determination took place on May 22,
2026.
The authority for the Commission's determination is contained in
section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and
in Part 210 of the Commission's Rules of Practice and Procedure (19 CFR
part 210).
By order of the Commission.
[[Page 31746]]
Issued: May 22, 2026.
Sharon Bellamy,
Supervisory Hearings and Information Officer.
[FR Doc. 2026-10549 Filed 5-27-26; 8:45 am]
BILLING CODE 7020-02-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on May 28, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.